Interleukin-12 (IL-12) has a role in various T and NK cell functions, including the induction of IFN-γ, and it is also currently a therapeutic prospect in both cancer for activation of cytolytic cells, as well as chronic hepatitis and colitis, where IL-12 blockade may reduce pathology (146, 147). The gene discussed is IFNG; the disease is cancer.